AGEN

5.9702.77%
GH

Garo H. Armen

Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman

Dr. Garo H. Armen, Ph.D. founded Agenus Inc. in 1994 and has been Chief Executive Officer since 1994 and serves as its Interim Chief Financial Officer & Principal Financial Officer since January 8, 2026. He serves as an Executive Chairman at MiNK Therapeutics, Inc. Dr. Armen serves as an Executive Chairman of Agenus Inc. He has been an Executive Director of Agenus Inc. since 1999. He had been the Chairman of Mink Therapeutics Inc. since July 2017. He serves as Director of Corporate Development at Valo Health. He serves as Director and Chief Executive Officer of AgenTus Therapeutics Limited. He served as the President of Agenus since January 2002 December 2019. Prior to Agenus Inc. he established Armen Partners, a money management firm specializing in biotechnology and pharmaceutical companies and was the architect of the widely publicized creation of the Immunex Lederle oncology business in 1993. Since 1990, he served as the Managing General Partner of Armen Partners, LP, an investment Partnership specializing in public and private healthcare and biotechnology investments. He previously served as Senior Vice President of Research for Dean Witter Reynolds, Research Division, focusing on the chemical and pharmaceutical industries and with E.F. Hutton & Company as first Vice President of research. He co-founded Protagenic Therapeutics, Inc. in September 2004 and served as its Executive Chairman of the Board. He serves as the Chairman of Elan Drug Delivery Inc. He begun his career on Wall Street as an analyst and investment banker at EF Hutton. Dr. Armen served as Chairman of Elan Corporation, plc from July 2002 to January 2005. He has been a Director of Philips Solid-State Lighting Solutions, Inc. (formerly, Color Kinetics Inc.) since 1998. He serves as a Director of ScrollMotion, Inc. He served as a Non Executive Director of Elan Corporation, plc from February 1994 to May 2006. He has served as an Associate Professor at the Merchant Marine Academy and as a Research Associate at the Brookhaven National Laboratory. In 2002, he founded the Children of Armenia Fund and serves as its Chairman. He received the Ellis Island Medal of Honor in 2004 for his humanitarian efforts and received the Sabin Humanitarian Award from the Sabin Vaccine Institute in 2006 for his achievements in biotechnology and progressing medical research. He was also Ernst & Young 2002 New York City Biotechnology Entrepreneur of the Year and received a Wings of Hope Award in 2005 from The Melanoma Research Foundation for his ongoing commitment to the melanoma community. Dr. Armen received his Ph.D. in Physical Chemistry from the Graduate Center, City University of New York in 1979, after which he worked as a research fellow at Brookhaven National Laboratories in Long Island, NY.

Positions